108 related articles for article (PubMed ID: 23603553)
1. Harmonization of antimicrobial susceptibility testing by broth microdilution for Rhodococcus equi of animal origin.
Riesenberg A; Feßler AT; Frömke C; Kadlec K; Klarmann D; Kreienbrock L; Werckenthin C; Schwarz S
J Antimicrob Chemother; 2013 Sep; 68(9):2173-5. PubMed ID: 23603553
[No Abstract] [Full Text] [Related]
2. Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K; Warner E; Ugorji U; Berghaus RD
J Clin Microbiol; 2015 Jan; 53(1):314-8. PubMed ID: 25378571
[TBL] [Abstract][Full Text] [Related]
3. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
Boyen F; Pasmans F; Haesebrouck F
Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
[No Abstract] [Full Text] [Related]
4. MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin.
Riesenberg A; Feßler AT; Erol E; Prenger-Berninghoff E; Stamm I; Böse R; Heusinger A; Klarmann D; Werckenthin C; Schwarz S
J Antimicrob Chemother; 2014 Apr; 69(4):1045-9. PubMed ID: 24275117
[TBL] [Abstract][Full Text] [Related]
5. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of Rhodococcus equi isolates from horse and man].
Fuhrmann C; Lämmler C
Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):54-9. PubMed ID: 9139629
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
[TBL] [Abstract][Full Text] [Related]
8. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
9. Pyogenic liver abscess due to Rhodococcus equi in an immunocompetent host.
Napoleão F; Damasco PV; Camello TC; do Vale MD; de Andrade AF; Hirata R; de Mattos-Guaraldi AL
J Clin Microbiol; 2005 Feb; 43(2):1002-4. PubMed ID: 15695730
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.
Coleman M; Kuskie K; Liu M; Chaffin K; Libal M; Giguère S; Bernstein L; Cohen N
Vet Microbiol; 2010 Nov; 146(1-2):175-8. PubMed ID: 20554401
[TBL] [Abstract][Full Text] [Related]
11. Rhodococcus equi isolation from sputum of patients with suspected tuberculosis.
Silva Pd; Miyata M; Sato DN; Santos AC; Mendes NH; Leite CQ
Mem Inst Oswaldo Cruz; 2010 Mar; 105(2):199-202. PubMed ID: 20428681
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two selective media for the recovery, isolation, enumeration and differentiation of Rhodococcus equi.
Muscatello G; Gilkerson JR; Browning GF
Vet Microbiol; 2007 Jan; 119(2-4):324-9. PubMed ID: 17084043
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial properties of the equine alpha-defensin DEFA1 against bacterial horse pathogens.
Bruhn O; Cauchard J; Schlusselhuber M; Gelhaus C; Podschun R; Thaller G; Laugier C; Leippe M; Grötzinger J
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):102-6. PubMed ID: 19211153
[TBL] [Abstract][Full Text] [Related]
14. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.
McNeil MM; Brown JM
Eur J Epidemiol; 1992 May; 8(3):437-43. PubMed ID: 1397208
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility testing of Rhodococcus equi: An interlaboratory test.
Riesenberg A; Kaspar H; Feßler AT; Werckenthin C; Schwarz S
Vet Microbiol; 2016 Oct; 194():30-35. PubMed ID: 26711505
[TBL] [Abstract][Full Text] [Related]
16. Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents.
McDermott PF; Bodeis-Jones SM; Fritsche TR; Jones RN; Walker RD
J Clin Microbiol; 2005 Dec; 43(12):6136-8. PubMed ID: 16333113
[TBL] [Abstract][Full Text] [Related]
17. Appearance of multidrug-resistant virulent Rhodococcus equi clinical isolates obtained in China.
Liu H; Wang Y; Yan J; Wang C; He H
J Clin Microbiol; 2014 Feb; 52(2):703. PubMed ID: 24478520
[No Abstract] [Full Text] [Related]
18. Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature.
Gundelly P; Suzuki Y; Ribes JA; Thornton A
Biomed Res Int; 2016; 2016():2737295. PubMed ID: 27631004
[TBL] [Abstract][Full Text] [Related]
19. Rhodococcus equi infection in a surgical wound.
Paasche SR
Clin Lab Sci; 2009; 22(3):141-5. PubMed ID: 19827407
[TBL] [Abstract][Full Text] [Related]
20. Investigation of an apparent outbreak of Rhodococcus equi bacteremia.
Langer AJ; Feja K; Lasker BA; Hinrikson HP; Morey RE; Pellegrini GJ; Smith TL; Robertson C
Diagn Microbiol Infect Dis; 2010 May; 67(1):95-100. PubMed ID: 20385352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
